{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79"}],"title":"Receipt of post-remission therapy"},{"measurements":[{"groupId":"OG000","value":"22"}],"title":"Did not receive post-remission therapy"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"101"}],"units":"Participants"}],"description":"Logistic regression will be used to analyze the association between standardized phase angle and receipt of post-remission therapy.","groups":[{"description":"Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.).\n\nbioelectric impedance analysis: Undergo bioelectric impedance analysis","id":"OG000","title":"Diagnostic (Bioelectric Impedance Analysis)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Up to 2 years","title":"Number of Participants With Receipt of Post-Remission Therapy","type":"SECONDARY","unitOfMeasure":"Participants"}